Rockwell Medical Inc. ($RMTI) reported that for the fourth quarter of the year, its sales were $13.4 million, or $0.7 million lower than Q4 2015. The company’s gross profit was $2.0 million compared to $2.1 million in Q4 2015. Its net loss was $5.1 million or ($0.10) per share compared to a $5.8 million loss or ($0.12) per share in Q4 2015. For the full year, its net loss was $19.8 million or ($0.39) per share versus $14.4 million or ($0.29) per share in 2015.
Celsion Inc. ($CLSN) announced that for the year ended December 31, 2016, the company’s net loss stood $22.1 million, or $0.85 per share, compared to a net loss of $22.5 million, or $1.03 per share, in 2015. its Research and development (R&D) costs were constant at $14.6 million in 2016 and 2015. The Company ended 2016 with $4.5 million of total cash, investments and accrued interest on these investments.